Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cervical Cancer
Value of adding HPV types to screening and triage tests is questioned
March 31st, 2005
According to a study from the United States, "Use of human papillomavirus (HPV) testing in cervical cancer prevention is increasing rapidly." "A DNA test for 13 HPV types that can cause cervical cancer is approved in the United States for co-screening with cytology of women {{>=}}30 years old and for triage of women of all ages with equivocal cytology. However, most infections with HPV are benign," state researchers. In their study, M. Schiffman and colleagues at the U.S. National Cancer Institute said they "evaluated trade-offs between specificity and sensitivity for approximately 40 HPV types in predicting cervical intraepithelial neoplasia 3...
Source: Women's Health Weekly (2005-03-31)
|
